LY2584702 Tosylate - CAS 1082949-68-5
Catalog number: 1082949-68-5
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Ribosomal S6 Kinase (RSK)
LY2584702 Tosylate is a selective, ATP-competitive p70S6K inhibitor with IC50 of 4 nM. Phase 1.
Publictions citing BOC Sciences Products
  • >> More
Related CAS:
1082949-67-4 (Free base)
White to off-white solid powder
4-(4-(4-(4-fluoro-3-(trifluoromethyl)phenyl)-1-methyl-1H-imidazol-2-yl)piperidin-1-yl)-1H-pyrazolo[3,4-d]pyrimidine 4-methylbenzenesulfonate; LY2584702; LY 2584702; LY-2584702; LYS6K2
Canonical SMILES:
1.A phase I trial of LY2584702 tosylate, a p70 S6 kinase inhibitor, in patients with advanced solid tumours.
Tolcher A1, Goldman J2, Patnaik A1, Papadopoulos KP1, Westwood P3, Kelly CS4, Bumgardner W4, Sams L4, Geeganage S4, Wang T4, Capen AR4, Huang J4, Joseph S4, Miller J4, Benhadji KA4, Brail LH4, Rosen LS5. Eur J Cancer. 2014 Mar;50(5):867-75. doi: 10.1016/j.ejca.2013.11.039. Epub 2014 Jan 15.
BACKGROUND: LY2584702 tosylate (hereafter referred to as LY2584702) is a potent, highly selective adenosine triphosphate (ATP) competitive inhibitor against p70 S6 kinase, a downstream component of the phosphatidylinositol-3-kinase signalling pathway which regulates cell proliferation and survival. LY2584702 exhibited anti-tumour activity in preclinical analysis.
2.A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours.
Hollebecque A1, Houédé N2, Cohen EE3, Massard C1, Italiano A2, Westwood P4, Bumgardner W5, Miller J5, Brail LH5, Benhadji KA5, Soria JC6. Eur J Cancer. 2014 Mar;50(5):876-84. doi: 10.1016/j.ejca.2013.12.006. Epub 2014 Jan 20.
BACKGROUND: LY2584702 tosylate (hereafter referred to as LY2584702) is an oral, selective ATP competitive inhibitor of p70 S6 kinase. Preclinical studies with LY2584702 demonstrated significant synergistic activity with erlotinib and everolimus. The primary objective was to determine a phase II dose and schedule. Secondary objectives included evaluation of safety, toxicity and pharmacokinetics of LY2584702 in combination with erlotinib or everolimus.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Ribosomal S6 Kinase (RSK) Products

CAS 821794-92-7 FMK

(CAS: 821794-92-7)

FMK is a potent, highly specific and irreversible ribosomal s6 kinase (RSK) inhibitor that covalently modifies the C-terminal kinase domain of RSK. Its IC50 val...

(CAS: 1627709-94-7)

LJI308 is a RSK inhibitor. LJI308 overcomes chemoresistance by eliminating cancer stem cells. LJI308 targets the CSC population and repress TNBC growth and diss...

LY-2584702 hydrochloride
(CAS: 1082948-81-9)

The hydrochloride salt form of LY2584702 which is a selective ATP competitive inhibitor of p70 S6 kinase. LY2584702 is still under Phase I trial for evaluating ...

CAS 501437-28-1 BI-D1870

(CAS: 501437-28-1)

BI-D1870 is an ATP-competitive inhibitor of S6 ribosome for RSK1/2/3/4 with IC50 of 31 nM/24 nM/18 nM/15 nM, respectively; 10- to 100-fold selectivity for RSK t...

BIX 02565
(CAS: 1311367-27-7)

BIX 02565, a RSK2 inhibitor, has also been found to significanltly influence sorts of adrenergic receptor subtypes involved in ascular tone and cardiac function...

CAS 821794-90-5 CMK

(CAS: 821794-90-5)

CMK is a RSK2 kinase inhibitor. Its IC50 value for Cdc5(L158G) is 36 nM. It is used in the preparation of serine/threonine kinase inhibitors.

CAS 839707-37-8 Pluripotin

(CAS: 839707-37-8)

Pluripotin, also known as SC-1, is a potent and selective activator of murine embryonic stem (ES) cell self-renewal. Pluripotin works through dual inhibition of...

CAS 871340-88-4 DG2

(CAS: 871340-88-4)

DG2 is a potent and selective inhibitor of p70 ribosomal S6 kinase 1 (S6K1) (IC50 = 9.1 nM) with ATP-competitive and cell-permeable properties.

CAS 1082949-67-4 LY2584702

(CAS: 1082949-67-4)

LY2584702 is an orally available inhibitor of p70S6K signaling, with potential antineoplastic activity.

(CAS: 1627710-50-2)

LJH685, binding to the RSK2 N-terminal kinase ATP-binding site, is a potent inhibitor that specificlly targets RSK with antiproliferative effects in MAPK pathwa...

CAS 1082949-68-5 LY2584702 Tosylate

LY2584702 Tosylate
(CAS: 1082949-68-5)

LY2584702 Tosylate is a selective, ATP-competitive p70S6K inhibitor with IC50 of 4 nM. Phase 1.

CAS 1255517-76-0 PF-4708671

(CAS: 1255517-76-0)

PF-4708671 is a novel cell-permeable inhibitor of S6K1. PF-4708671 specifically inhibits the S6K1 isoform with a Ki of 20 nM and IC50 of 160 nM. PF-4708671 pre...

Chemical Structure

CAS 1082949-68-5 LY2584702 Tosylate

Quick Inquiry

Verification code

Featured Items